The speedster's injury has added to the team's woes as Pakistan's fast-bowling resources are already depleted due to the absence of Shaheen Shah Afridi and Harris Rauf. Rauf debuted in the first Test but injured his quadriceps and is now out of the series.
A medication in development for obstructive sleep apnoea (OSA) showed promising results after being tested in humans for the first time by Flinders University researchers.
Mumbai (Maharashtra) [India], December 8 (ANI/PRNewswire): Leading diversified professional services and investment management company Colliers (NASDAQ: CIGI) (TSX: CIGI) has released its 2023 Global Investor Outlook report, which has found that the stabilisation of global real estate market
On Dec. 11, 2021, NASA's Neil Gehrels Swift Observatory and Fermi Gamma-ray Space Telescope detected a blast of high-energy light from the outskirts of a galaxy around 1 billion light-years away. The event has rattled scientists' understanding of gamma-ray bursts (GRBs), the most powerful ev
A memorandum of understanding was signed between IDFC FIRST Bank and NASSCOM COE for appointing the lender as a preferred banking Partner for startups, at an event in Bengaluru, attended by startup founders.
Singapore, December 6 (ANI/PRNewswire): Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today released a new State of the Internet report that indicates a severe risk to the financial services sector in Asia-Pacific and Japan (APJ) region, as
Making the most of the batting-friendly conditions in Rawalpindi, Root switched to a left-handed mode while batting against right-arm spinner Zahid Mahmood for the first two deliveries of his sixth over
Tampa (Florida) [US], December 3 (ANI/PRNewswire): VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled 'Sirolimus Coated Balloon in PAD Treatment: Choice o
The Central Drugs Standard Control Organization (CDSCO) has approved India's first intra-nasal vaccine for COVID for restricted use in emergency situations in people aged 18 and up.